This study aims to establish the first county-level, population-based prospective cohort in Taining County, Fujian Province, China. The cohort will include at least 20,000 residents aged 18 years or older. The project will systematically collect questionnaires, physical measurements, laboratory tests, imaging data, and biological samples to build a multi-dimensional health database and biobank. Through 3-year follow-up, the study seeks to reveal the epidemiological patterns and risk factors of chronic diseases, characterize the natural course of multimorbidity and aging syndromes, and develop a comprehensive chronic disease management model suitable for rural and mountainous regions.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Age ≥18 years, male or female.
* Resident of Taining County for ≥6 months and expected to remain in the county for at least the next 3 years.
* Full civil capacity and able to understand study procedures.
* Willing to voluntarily participate and provide written informed consent.
* Able to complete baseline survey and follow-up visits.
Exclusion Criteria:
* Refusal to sign informed consent.
* Severe psychiatric disorders or cognitive impairment preventing participation.
* End-stage disease with expected survival \<1 year.
* Long-term migrants (≥6 months per year outside the county), unable to guarantee follow-up.
* Participation in other clinical studies that may interfere with this research.
Primary outcome measure(s)
Incidence of Major Adverse Cardiovascular Events (MACE) — Up to 36 months Composite outcome including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. Events will be ascertained through active follow-up and confirmed using medical records and hospital discharge summaries.
Trial sites (1)
Facility
City
Region
Status
The First Affiliated Hospital of Fujian Medical University
Fuzhou
Fujian
Recruiting
More First Affiliated Hospital of Fujian Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.